Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Stem Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT00169598
What this trial is testing

Remission Evaluation Before Intensified Treatment in Lymphoma: Impact of Positron Emission Tomography (PET) Using Fluorine-18-Floro-Deoxyglucose (FDG) in the Therapeutic Prescription. Medico-Economic Randomised Study

Who this might be right for
Lymphoma
Hospices Civils de Lyon 80
Testing effectiveness (Phase 2)Study completedNCT06865352
What this trial is testing

Safety and Preliminary Efficacy of Donor-derived Anti-leukemia Cytotoxic T Lymphocytes for the Prevention of Leukemia Relapse in Children Given Haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Lymphoblastic Leukemia ALLAcute Myeloid Leukemia (AML)
Fondazione IRCCS Policlinico San Matteo di Pavia 15
Very early researchWithdrawnNCT04051047
What this trial is testing

Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma

Who this might be right for
Glial Tumor of BrainDiffuse Intrinsic Pontine GliomaGlioma
University of Michigan Rogel Cancer Center
Not applicableUnknownNCT06045065
What this trial is testing

Preclinical Brain Tumor Models

Who this might be right for
Brain MetastasesDiffuse Gliomas
Assistance Publique Hopitaux De Marseille 60
Testing effectiveness (Phase 2)WithdrawnNCT01170052
What this trial is testing

Bendamustine and Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Mantle Cell Lymphoma
Charite University, Berlin, Germany 20
Large-scale testing (Phase 3)Study completedNCT00469144
What this trial is testing

IV Busulfan With Allo-BMT: Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic SyndromeLeukemiaAcute Myeloid Leukemia
M.D. Anderson Cancer Center 233
Not applicableEnded earlyNCT00966498
What this trial is testing

Peripheral Blood Stem Cell Transplant (PBSCT) in Children With High Risk or Recurrent Solid Tumors

Who this might be right for
High Risk Solid TumorsRecurrent Solid Tumors
Emory University 3
Testing effectiveness (Phase 2)Study completedNCT01067287
What this trial is testing

Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation

Who this might be right for
Multiple Myeloma
Beth Israel Deaconess Medical Center 35
Not applicableNot Yet RecruitingNCT07825714
What this trial is testing

Metagenomic Sequencing Across the Infectious Disease Risk and Care Continuum

Who this might be right for
Infectious DiseasesImmunocompromised HostOpportunistic Infections
Karius, Inc. 10,000
Testing effectiveness (Phase 2)Study completedNCT00916058
What this trial is testing

Conditioning Regimen of Bendamustine and Melphalan Followed by Transplant in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Weill Medical College of Cornell University 57
Testing effectiveness (Phase 2)Ended earlyNCT00589602
What this trial is testing

T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
The Cleveland Clinic 13
Testing effectiveness (Phase 2)Study completedNCT00144807
What this trial is testing

ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large Cell Lymphoma
Lymphoma Study Association 128
Testing effectiveness (Phase 2)Study completedNCT00066092
What this trial is testing

Pegfilgrastim PBPC Mobilization Study

Who this might be right for
LymphomaHodgkin's LymphomaNon-Hodgkin's Lymphoma+2 more
Amgen 41
Testing effectiveness (Phase 2)Study completedNCT00045136
What this trial is testing

Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Poniard Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT00001880
What this trial is testing

Stem Cell Transplantation for Metastatic Solid Tumors

Who this might be right for
Neoplasm Metastasis
National Heart, Lung, and Blood Institute (NHLBI) 42
Large-scale testing (Phase 3)Study completedNCT00008229
What this trial is testing

Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT05843253
What this trial is testing

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Who this might be right for
High Grade GliomaDiffuse Intrinsic Pontine GliomaAnaplastic Astrocytoma+7 more
Nationwide Children's Hospital 120
Testing effectiveness (Phase 2)WithdrawnNCT03168100
What this trial is testing

2017-03: A Single-Arm, Open-label Study of Anti-Signaling Lymphocytic Activation Molecule F7 (Anti-SLAMF7) Monoclonal Antibody (mAb) Therapy After Autologous Stem Cell Transplant in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas
Early research (Phase 1)Study completedNCT00058292
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Northwestern University 44
Not applicableStudy completedNCT00764829
What this trial is testing

Blood Samples to Evaluate Biomarkers of Donor Chimerism

Who this might be right for
LeukemiaHodgkins DiseaseNon-hodgkins Lymphoma+1 more
Fred Hutchinson Cancer Center 80
Next Page